Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Identification and Validation of a Novel PANoptosis-related Gene Signatured for Osteosarcoma as Prognostic Model.

  • 2024-11-01
  • Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 34(11)

Study Design

Type
Observational
Methods
Observational study using transcriptomic data from GEO and TARGET databases, LASSO Cox-regression, Kaplan-Meier survival analysis, time-dependent ROC curves.
Funding
Unclear

Objective

To construct and validate a prognostic model for osteosarcoma prognostication and therapeutic potential of PANoptosis- related genes.

Study design

Observational study. Place and Duration of the Study: Department of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China, from August 2021 to January 2024.

Methodology

Transcriptomic data from the GEO and TARGET databases were utilised to construct and validate a prognostic model for osteosarcoma. The analysis involved the use of the LASSO Cox-regression method with the Glmnet R package to identify key PANoptosis-related genes. Differential gene expression analysis was conducted using the Limma R package, and model validation was performed using Kaplan-Meier survival analysis and time-dependent ROC curves.

Results

This model, derived from five key PANoptosis-related genes, demonstrated significant predictive capability for patient survival across training and validation cohorts. Further analysis confirmed the model's effectiveness and identified metastasis stage and risk scores as the robust independent prognostic indicators.

Conclusion

The prognostic model offers a novel tool for osteosarcoma prognostication and underscores the therapeutic potential of targeting PANoptosis-related pathways.

Key words

PANoptosis-related genes, Osteosarcoma, Prognosis, Bioinformatics, Tumour micro-environment.

Research Insights

    Back to top